big changes in chronic hepatitis C therapy with two new oral antivirals, Galexos (simeprevir) and Sovaldi (sofosbuvir)
You'll see big changes in chronic hepatitis C therapy with two new oral antivirals, Galexos (simeprevir) and Sovaldi (sofosbuvir).
Galexos (gah-LEX-ohs) is similar to Incivek (telaprevir) and Victrelis (boceprevir).
Galexos' advantage is that it's dosed once daily...seems to be better tolerated...and has fewer interactions than Incivek or Victrelis.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote